4'-(Methylsulfonyl)acetophenone CAS 10297-73-1 Purity >99.0% (HPLC)

Chemical Name: 4'-(Methylsulfonyl)acetophenone CAS: 10297-73-1 Purity: >99.0% (HPLC)  Appearance: White to Light Yellow Crystal High Quality, Commercial Production Contact: Dr. Alvin Huang Mobile/Wechat/WhatsApp: +86-15026746401 E-Mail: alvin@ruifuchem.com

Products Details

Chemical Properties:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moistureShanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4'-(Methylsulfonyl)acetophenone (CAS: 10297-73-1) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com
Item Specifications
Appearance White to Light Yellow Crystal
Purity / Analysis Method >99.0% (GC) 
Melting Point 126.0~129.0℃ 
Water (by Karl Fischer) <0.50%
Total Impurities <1.00%
Infrared Spectrum Conforms to Structure
Proton NMR Spectrum Conforms to Structure
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Description:

Specifications:

Package & Storage:

Chemical Name 4'-(Methylsulfonyl)acetophenone  
Synonyms 4-(Methylsulfonyl)acetophenone; 4-Methylsulphonylacetophenone; 4-Methyi Sulfonyl Acetophenone; 4-(Methyl Sulfonyl) Acetophenone; 1-(4-(Methylsufonyl)phenyl)ethanone; 1-[4-(Methylsulfonyl)phenyl]ethan-1-one; p-Acetylphenyl Methyl Sulfone; p-Methylsulfonylacetophenone; Etoricoxib Impurity A (USP Related Compound A) 
CAS Number 10297-73-1 
CAT Number RF2932
Stock Status In Stock, Production Capacity 20 Tons per Month   
Molecular Formula C9H10O3S 
Molecular Weight 198.24  
Melting Point 126.0~129.0℃(lit.)
Hazard Class  Irritant
HS Code 29144000
Brand Ruifu Chemical

Advantages:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com  15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals. Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc. Advantages? Superior quality, affordable price, professional services and technical support, fast delivery. Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc. SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers. Factory AuditFactory audit welcome. Please make an appointment in advance. MOQ? No MOQ. Small order is acceptable. Delivery Time? If within stock, three days delivery guaranteed. TransportationBy Express (FedEx, DHL), by Air, by Sea. Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided. Custom SynthesisCan provide custom synthesis services to best fit your research needs. Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

FAQ:

Stable Supply: Maintain reasonable stock    

Professional Service: One stop purchasing service

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

Fast Delivery: If within stock, three days delivery guaranteed

High Quality: Established a complete quality assurance system

Application:

4'-(Methylsulfonyl)acetophenone (CAS: 10297-73-1) is an important raw material and intermediate used in organic synthesis, pharmaceuticals. 4'-(Methylsulfonyl)acetophenone is an impurity of Etoricoxib (CAS: 202409-33-4), which is a specific inhibitor of COX-2. Etoricoxib is a kind of highly selective cyclooxygenase-2 (COX-2) inhibitors developed by the Merck company. Etoricoxib was first approved for entering into market in 2002 in the UK, followed by the marketing countries and regions including the European Union, Asia, Australia and Latin America.  Until the end of 2013, it has been approved for marketing in 97 countries for being widely used in treatment of osteoarthritis (OA), rheumatoid arthritis, ankylosing spondylitis, chronic low back pain, acute gouty arthritis, primary dysmenorrhea and postoperative pain, and other diseases.  Etoricoxib has also entered into market in Taiwan and Hong Kong of China.  It had entered into market in Chinese mainland in 2008 with the approved indications being acute gouty arthritis and OA and another indication being primary dysmenorrhea in the second half year of 2014.

Sufficient Capacity: Sufficient facilities and technicians

OEM Package: Custom package and label available

Contact us

Please feel free to give your inquiry in the form below We will reply you in 24 hours